Package 69238-1535-2

{"route": ["ORAL"], "spl_id": "cf085b2b-564e-4109-90e7-1d27fcbca810", "openfda": {"nui": ["N0000175694", "M0002356", "N0000182137", "N0000185506"], "unii": ["2MRO291B4U"], "rxcui": ["1366192"], "spl_set_id": ["a526ad73-d3c1-40b7-8e71-426b01cdea27"], "pharm_class_cs": ["Benzodiazepines [CS]"], "pharm_class_epc": ["Benzodiazepine [EPC]"], "pharm_class_moa": ["Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]"], "manufacturer_name": ["Amneal Pharmaceuticals NY LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, GLASS in 1 CARTON (69238-1535-2)  / 120 mL in 1 BOTTLE, GLASS", "package_ndc": "69238-1535-2", "marketing_start_date": "20181022"}], "brand_name": "Clobazam", "product_id": "69238-1535_cf085b2b-564e-4109-90e7-1d27fcbca810", "dosage_form": "SUSPENSION", "pharm_class": ["Benzodiazepine [EPC]", "Benzodiazepines [CS]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]"], "product_ndc": "69238-1535", "dea_schedule": "CIV", "generic_name": "Clobazam", "labeler_name": "Amneal Pharmaceuticals NY LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Clobazam", "active_ingredients": [{"name": "CLOBAZAM", "strength": "2.5 mg/mL"}], "application_number": "ANDA210039", "marketing_category": "ANDA", "marketing_start_date": "20181022", "listing_expiration_date": "20261231"}